Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Epidemiology

O-Antigen Diversity among Acinetobacter baumanniiStrains from the Czech Republic and Northwestern Europe, as Determined by Lipopolysaccharide-Specific Monoclonal Antibodies

Ralph Pantophlet, Alexandr Nemec, Lore Brade, Helmut Brade, Lenie Dijkshoorn
Ralph Pantophlet
Division of Medical and Biochemical Microbiology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandr Nemec
National Institute of Public Health, Prague, Czech Republic; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lore Brade
Division of Medical and Biochemical Microbiology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helmut Brade
Division of Medical and Biochemical Microbiology, Research Center Borstel, Borstel, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lenie Dijkshoorn
Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.39.7.2576-2580.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

O-antigen-specific monoclonal antibodies (MAbs) are currently being generated to develop an O-serotyping scheme for the genusAcinetobacter and to provide potent tools to study the diversity of O-antigens among Acinetobacter strains. In this report, Acinetobacter baumannii strains from the Czech Republic and from two clonal groups identified in Northwestern Europe (termed clones I and II) were investigated for their reactivity with a panel of O-antigen-specific MAbs generated againstAcinetobacter strains from various species. The bacteria were characterized for their ribotype, biotype, and antibiotic susceptibility and the presence of the 8.7-kb plasmid pAN1. By using the combination of these typing profiles, the Czech strains could be classified into four previously defined groups (A. Nemec, L. Janda, O. Melter, and L. Dijkshoorn, J. Med. Microbiol. 48:287–296, 1999): two relatively homogeneous groups of multiresistant strains (termed groups A and B), a heterogeneous group of other multiresistant strains, and a group of susceptible strains. O-antigen reactivity was observed primarily with MAbs generated againstAcinetobacter calcoaceticus and Acinetobacter baumannii strains. A comparison of reaction patterns confirmed the previously hypothesized clonal relationship between group A and clone I strains, which are also similar in other properties. The results show that there is limited O-antigen variability among strains with similar geno- and phenotypic characteristics and are suggestive of a high prevalence of certain A. baumannii serotypes in the clinical environment. It is also shown that O-antigen-specific MAbs are useful for the follow-up of strains causing outbreaks in hospitals.

The potential of members of the genus Acinetobacter to cause infection has been known for decades (7-9, 11, 18). However, only after improvement of species classification within the genus as a result of DNA-DNA hybridization studies (1, 3, 19) was it possible to gain insight into the ecology and clinical significance of individual Acinetobacter species (20). Of these, Acinetobacter baumannii (DNA group 2) has been isolated predominantly from clinical specimens of human origin and is clearly the main species associated with outbreaks of nosocomial infections (21). However, the reliable identification of this species in bacteriological laboratories is hampered by the close pheno- and genotypic relatedness of A. baumannii to three other species within the genus (5), two of which (unnamed DNA groups 3 and 13TU) (19) are known to also cause hospital-acquired infections (21). Due to the successful use of lipopolysaccharides (LPS) as taxonomic markers for a variety of gram-negative bacteria, we have decided to generate O-antigen-specific monoclonal antibodies (MAbs) against the LPS ofAcinetobacter strains, with the aim of developing an identification scheme for this group of bacteria based on the chemical and antigenic structure of the O-polysaccharide of their LPS.

In a previous study, the pheno- and genotypic similarities amongA. baumannii strains isolated in the Czech Republic were analyzed (12). Based on the results, these isolates could be classified into four groups: two relatively homogeneous groups of predominantly multiresistant strains (termed groups A and B) comprising both sporadic and outbreak-associated isolates, a heterogeneous group of other multiresistant strains, and a group of mainly susceptible strains (12). The features of groups A and B were found to be highly similar to those of two outbreak-relatedA. baumannii clonal groups, clones I and II, which were identified among hospital isolates in Northwestern Europe (6). In this study, we analyzed the O-antigenic relationship among these Czech strains, in comparison to a number of clone I and II strains, by using O-antigen-specific MAbs. The aim of the study was to gain insight into the prevalence of putativeAcinetobacter O-serotypes (i.e., the O-antigen diversity), within the Czech Republic in particular, but also within the general clinical environment.

MATERIALS AND METHODS

Bacteria.The Acinetobacter strains investigated in this study are listed in Table1(n = 65). They consisted of a selection of clinical isolates from the Czech Republic (n = 52) and Northwestern Europe (The Netherlands, United Kingdom, Belgium, and Denmark [n = 13]). Most strains were originally isolated from burn wounds, sputum, or urine. Forty-two Czech strains were identified previously as A. baumannii by ribotyping and characterized by antibiotic susceptibility, biotype, and plasmid profile (12). These strains were selected for this study from a set of 77 A. baumannii isolates (12) to be as heterogeneous as possible in their properties, geographical origin, and time of isolation, thus excluding multiple isolates of the same strain from one locality. Ten previously uncharacterized strains were added to broaden the geographical heterogeneity of the strains from the Czech Republic. The 13 strains from Northwestern Europe (Table1) were identified previously as A. baumannii by DNA-DNA hybridization (6). The geno- and phenotypic characteristics of two of these strains, RUH 875 and RUH 134, have been compared recently to those of clinical isolates from the Czech Republic (12). For the present study, the additional Northwestern European strains and the additionally selected Czech strains were characterized for their ribotype, biotype, and antibiotic susceptibility as described previously (12). The presence of an 8.7-kb-plasmid, termed pAN1, was determined with a digoxigenin-labeled probe prepared from pAN1 of A. baumanniiNIPH 632 (12). All strains used in this study were preserved in glycerol stocks at −80°C.

View this table:
  • View inline
  • View popup
Table 1.

Geno- and phenotypic properties of A. baumannii strains investigated in this study, their reactivity with O-antigen-specific MAbs in dot and Western blots, and O-banding patterns following acid hydrolysis of membrane-bound LPS and immunostaining with MAb A6 for strains that did not react with any MAb

Whole-cell lysates and proteinase K digestion.Preparation of whole-cell lysates and proteinase K treatment of these lysates were performed as described in another study (14). They were stored at −20°C and heated (100°C, 5 min) prior to use.

MAbs.The MAbs used in this study are shown in Table2. Their generation and serological characterization have been described in detail in other studies (15-17; R. Pantophlet, J. A. Severin, A. Nemec, L. Brade, L. Dijkshoorn, and H. Brade, submitted for publication; R. Pantophlet, L. Brade, and H. Brade, submitted for publication). They included MAbs against strains from the clinically more important species such as A. baumannii, DNA group 3, and DNA group 13TU, as well as MAbs against other species within the genus. All antibodies were stored at −20°C when not in use.

View this table:
  • View inline
  • View popup
Table 2.

O-antigen-specific MAbs used in this study and their corresponding immunogens

Serological assays.Dot blotting and Western blotting were performed as described previously (15) with proteinase K-treated bacterial lysates as antigens. Acid hydrolysis of membrane-bound LPS and detection of its lipid A moiety with antibody were performed as described elsewhere (13) with 1% acetic acid and MAb A6 against bisphosphoryl lipid A (10).

RESULTS AND DISCUSSION

The properties and epidemiological data of the 65 strains are shown in Table 1. Examples of EcoRI ribotypes are shown in Fig. 1. According to their ribotypes, all 10 additonally selected Czech strains were identified as A. baumannii. These strains were all resistant to at least three of nine antibiotics tested. Based on their EcoRI ribotypes and biotypes, seven of these strains (ribotype I, biotype 6 or 11) could be allocated to group A, and one strain (ribotype II, biotype 2) could be allocated to group B. The remaining two strains (ribotype X, biotype 2) were placed in the third group of multiresistant strains. A plasmid with a size of approximately 8.7 kb, termed pAN1 (12), was present in all of the additionally selected strains, which were placed in group A, as well as in the strain allocated to group B.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Examples of EcoRI ribotypes observed forA. baumannii strains isolated in the Czech Republic. Lanes: 1, molecular weight marker (phage λ DNA digested withHindIII and StyI); 2, strain NIPH 7; 3, strain NIPH 10; 4, strain NIPH 24; 5, strain NIPH 60; 6, strain NIPH 615. Strains NIPH 7 and NIPH 24 are representative of isolates allocated to groups A and B, respectively.

Proteinase K-digested lysates of all strains were then tested by dot blotting with the O-antigen-specific MAbs listed in Table 2. Strains giving positive reactions were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting to confirm the reactivity observed in the dot blot with the respective MAb. O-antigen-reactivity was observed to be nearly exclusively with MAbs generated against A. calcoacetius and A. baumannii strains (Table 1). Group A isolates reacted with MAbs S48-3-13 (n = 17) and S51-3 (n = 5), generated against the O-antigens of an A. baumannii strain and an A. calcoaceticus strain, respectively. It is interesting in this context that clone I strains also reacted with MAb S48-3-13. Moreover, in both group A and clone I strains, plasmid pAN1 was found. Together with the previously noted similarities between group A and clone I reference strain RUH 875 (12), this finding strongly supports the hypothesis that group A and clone I strains are clonally related. The five remaining group A strains that reacted with MAb S51-3 may represent a subclonal group, judging from the similarities in their ribotypes and biotypes and the presence of plasmid pAN1 with the other group A strains. Only one other strain (NIPH 10, in the third group of multiresistant Czech strains) also reacted with MAb S51-3. Interestingly, plasmid pAN1 was also found in this strain, and its ribotype was highly similar to theEcoRI ribotype observed for group A and clone I strains (only one band position difference; Fig. 1). Plasmid pAN1 was originally isolated from A. baumannii strain NIPH 632 (12). Although its function and encoded properties are not known, it has been found in all (geographically highly diverse) strains with the EcoRI ribotype specific to clone I strains from Northwestern Europe, but rarely in other A. baumanniistrains. This plasmid may thus serve as a clonal marker; however, further studies are needed to assess its role, if any, in the epidemicity of A. baumannii strains. Group B strains reacted exclusively with MAb S53-32, whereas clone II strains reacted primarily with MAb S48-3-17. A clonal relationship between these two groups of strains therefore seems unlikely. However, it must be noted here that clone II strains were originally delineated based primarily on their amplified fragment length polymorphism profile (6); two different EcoRI ribotype patterns were observed among these strains (Table 1) which were similar to the EcoRI ribotypes observed for two other outbreak-related strains that could not be allocated unambiguously to either clone I or II (6). Thus, the possibility of variants or subclones within this particular clonal group cannot be excluded. MAb reactivity with the other Czech strains included in this study was sporadic: two strains reacted with MAb S53-32, two reacted with MAb S48-3-17, and one reacted with MAb S53-25. The latter antibody was generated against the O-antigen of a strain belonging to genomic species 16, and its reactivity with A. baumannii strains would appear to be unusual at first glance. However, we have shown recently (14) that certain O-antigenic determinants may occur in different genomic species. This seems to be true as well for the epitope recognized by MAb S53-25. The generation of more O-antigen-specific antibodies against structurally defined epitopes of the O-polysaccharide chains will help clarify which epitopes determine species specificity and which do not. The high degree of reactivity among the homogeneous groups of multiresistant strains indicates limited O-antigen variation and supports the view that such strains are of a common clonal origin.

By using a method to visualize any LPS via its lipid A moiety with antibody in a Western blot following acid hydrolysis of the membrane-bound antigen (13), it was possible to define the putative O-serotypes of some strains that had not reacted with any of the MAbs used in the present study. Six novel banding patterns (labeled 1 to 6) were observed among 10 of the 17 strains, which did not react with any of the O-antigen-specific MAbs used in this study (Table 1 and Fig. 2). The lack of observation of a pattern for all strains has been noted in other studies (15, 16) and is probably because these strains have a reduced level of O-antigen expression or produce LPS that lacks an O-antigen. This is also an example how such antibodies may help analytical biochemists select those LPS that are worth being analyzed structurally.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Representative Western blot of A. baumannii strains that did not react with any of the O-antigen-specific MAbs used in this study following acid hydrolysis (1 h in 1% acetic acid at 100°C) of membrane-bound LPS and immunostaining with lipid A-specific MAb A6. Bacteria are, from left to right, strain NIPH 33 (lane 1), strain NIPH 335 (lane 2), strain NIPH 4 (lane 3), strain NIPH 45 (lane 4), strain NIPH 70 (lane 5), and strain NIPH 201 (lane 6).

The findings presented above suggest that certain A. baumannii serotypes may be more prevalent than others in hospital settings. In the Czech Republic, these would appear to be primarily the serotypes defined by MAbs S48-3-13, S53-32, and S51-3. In Northwestern Europe, the serotypes defined by MAbs S48-3-13 and S48-3-17 would appear to be most prevalent. Recent screening studies (R. Pantophlet, J. A. Severin, A. Nemec, L. Brade, L. Dijkshoorn, and H. Brade, submitted for publication) have shown that the serotypes defined by the MAbs mentioned above are also present in other Eastern European countries, such as Hungary, Bulgaria, and Poland. In Hungary and Bulgaria, the S51-3 serotype was found, whereas in Poland, the serotypes defined by MAbs S48-3-17 and S53-32 were identified among a number of strains tested. The serotypes defined by these three MAbs were also found in Italy. In Germany, the serotypes defined by MAbs S48-3-13 and S53-32 appear to be more common, whereas the S48-3-17 and S51-3 serotypes are found only sporadically. However, a large-scale study will be necessary to depict more precisely the prevalence and geographical spread of these and other serotypes. Thus, with the generation of more O-antigen-specific MAbs, it will be possible not only to complete a serotyping scheme for Acinetobacter, but also to further define the prevalence of Acinetobacterserotypes in clinical settings worldwide.

ACKNOWLEDGMENTS

The technical assistance of M. Willen is gratefully acknowledged.

This study was supported in part by research grant 310/98/1602 of the Grant Agency of the Czech Republic.

FOOTNOTES

    • Received 7 February 2001.
    • Returned for modification 16 April 2001.
    • Accepted 29 April 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bouvet P. J. M.,
    2. Grimont P. A. D.
    Taxonomy of the genus Acinetobacter with recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii.Int. J. Syst. Bacteriol.361986228240
    OpenUrlCrossRef
  2. 2.
    1. Bouvet P. J. M.,
    2. Grimont P. A. D.
    Identification and biotyping of clinical isolates of Acinetobacter.Ann. Inst. Pasteur (Paris)1381987569578
    OpenUrl
  3. 3.↵
    1. Bouvet P. J. M.,
    2. Jeanjean S.
    Delineation of new proteolytic genomic species in the genus Acinetobacter.Res. Microbiol.1401989291299
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.
    1. Dijkshoorn L.,
    2. Tjernberg I.,
    3. Pot B.,
    4. Michel M. F.,
    5. Ursing J.,
    6. Kersters K.
    Numerical analysis of cell envelope protein profiles of Acinetobacter strains classified by DNA-DNA hybridization.Syst. Appl. Microbiol.131990338344
    OpenUrl
  5. 5.↵
    1. Dijkshoorn L.
    Acinetobacter—microbiology Acinetobacter: microbiology, epidemiology, infections, management. Bergogne-Bérézin E., Joly-Guillou M. L., Towner K. J. 1996 37 69 CRC Press Boca Raton, Fla
  6. 6.↵
    1. Dijkshoorn L.,
    2. Aucken H.,
    3. Gerner-Smidt P.,
    4. Janssen P.,
    5. Kaufmann M. E.,
    6. Garaizar J.,
    7. Ursing J.,
    8. Pitt T. L.
    Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods.J. Clin. Microbiol.34199615191525
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Glew R. H.,
    2. Moellering R. C.,
    3. Kunz L. J.
    Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.Medicine5619777996
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Hoppe M.,
    2. Potel J.,
    3. Malottke R.
    Clinical importance of Acinetobacter calcoaceticus isolations from blood cultures and venecatheters.Zentbl. Bakteriol.25619838086
    OpenUrl
  9. 9.↵
    1. Juni E.
    Genus III. Acinetobacter Brisou and Prévot 1954, 727AL Bergey's manual of systematic bacteriology Krieg N. R. 1 1984 303 307 Williams & Wilkins Baltimore, Md
    OpenUrl
  10. 10.↵
    1. Kuhn H. M.,
    2. Brade L.,
    3. Appelmelk B. J.,
    4. Kusumoto S.,
    5. Rietschel E. T.,
    6. Brade H.
    Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.Infect. Immun.60199222012210
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Lautrop H.
    Acinetobacter Brisou and Prévot 1954 Bergey's manual of determinative bacteriology 8th ed. Buchanan R. E., Gibbons N. E. 1974 436 438 Williams & Wilkins Baltimore, Md
  12. 12.↵
    1. Nemec A.,
    2. Janda L.,
    3. Melter O.,
    4. Dijkshoorn L.
    Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic.J. Med. Microbiol.481999287296
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Pantophlet R.,
    2. Brade L.,
    3. Brade H.
    Detection of lipid A by monoclonal antibodies in S-form lipopolysaccharide after acidic treatment of immobilized LPS on Western blot.J. Endotoxin Res.419978995
    OpenUrl
  14. 14.↵
    1. Pantophlet R.,
    2. Brade L.,
    3. Dijkshoorn L.,
    4. Brade H.
    Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.J. Clin. Microbiol.36199812451250
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Pantophlet R.,
    2. Brade L.,
    3. Brade H.
    Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.Clin. Diagn. Lab. Immunol.61999323329
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Pantophlet R.,
    2. Brade L.,
    3. Brade H.
    Use of a murine O-antigen-specific monoclonal antibody to identify Acinetobacter strains of unnamed genomic species 13 Sensu Tjernberg and Ursing.J. Clin. Microbiol.37199916931698
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Pantophlet R.,
    2. Haseley S. R.,
    3. Vinogradov E. V.,
    4. Brade L.,
    5. Holst O.,
    6. Brade H.
    Chemical and antigenic structure of the O-polysaccharide of the lipopolysaccharide from two Acinetobacter haemolyticus strains differing only in the anomeric configuration of one glycosyl residue in their O-antigen.Eur. J. Biochem.2631999587595
    OpenUrlPubMed
  18. 18.↵
    1. Taplin D.,
    2. Rebell G.,
    3. Zaias N.
    The human skin as a source of Mima-Herellea infections.JAMA1861963166168
    OpenUrlCrossRef
  19. 19.↵
    1. Tjernberg I.,
    2. Ursing J.
    Clinical strains of Acinetobacter classified by DNA-DNA hybridization.APMIS971989595605
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Towner K. J.,
    2. Bergogne-Bérézin E.,
    3. Fewson C. A.
    Acinetobacter: portrait of a genus The biology of Acinetobacter: taxonomy, clinical importance, molecular biology, physiology, industrial relevance. Towner K. J., Bergogne-Bérézin E., Fewson C. A. 1991 1 24 Plenum Press New York, N.Y
  21. 21.↵
    1. Towner K. J.
    Clinical importance and antibiotic resistance of Acinetobacter spp.J. Med. Microbiol.461997721746
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
O-Antigen Diversity among Acinetobacter baumanniiStrains from the Czech Republic and Northwestern Europe, as Determined by Lipopolysaccharide-Specific Monoclonal Antibodies
Ralph Pantophlet, Alexandr Nemec, Lore Brade, Helmut Brade, Lenie Dijkshoorn
Journal of Clinical Microbiology Jul 2001, 39 (7) 2576-2580; DOI: 10.1128/JCM.39.7.2576-2580.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
O-Antigen Diversity among Acinetobacter baumanniiStrains from the Czech Republic and Northwestern Europe, as Determined by Lipopolysaccharide-Specific Monoclonal Antibodies
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
O-Antigen Diversity among Acinetobacter baumanniiStrains from the Czech Republic and Northwestern Europe, as Determined by Lipopolysaccharide-Specific Monoclonal Antibodies
Ralph Pantophlet, Alexandr Nemec, Lore Brade, Helmut Brade, Lenie Dijkshoorn
Journal of Clinical Microbiology Jul 2001, 39 (7) 2576-2580; DOI: 10.1128/JCM.39.7.2576-2580.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS AND DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Acinetobacter
Antibodies, Monoclonal
antigenic variation
O Antigens

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X